Metabolic signaling research
Retatrutide
Three metabolic targets, one peptide: GLP-1, GIP and glucagon in weight-regulation research.
Packaging illustration
Delivery terms are confirmed before payment
Da Nang: about 30 minutes · every other Vietnam address: 1–2 days
Retatrutide reconstitution calculator
- Labeled vial
- Swabs + syringe
- Written confirmation
Research use only
RetatrutideThree receptor pathways in one molecule
A clear starting point. Follow the research, unpack the terminology and compare related profiles.
What is Retatrutide?
Retatrutide brings GLP-1, GIP and glucagon receptor activity into one molecule. Researchers investigate how these pathways interact in appetite, energy expenditure and weight regulation, giving it a distinct profile alongside single- and dual-receptor compounds.
What do researchers investigate?
Energy expenditure and metabolic signalling
Comparative research against dual-agonist peptides
Unpack the terminology
Tap a term to see what it means.
Receptor
A protein that recognises a signal. Studying receptor binding helps explain which cellular pathway a molecule may engage.
Agonist
A molecule that activates a receptor. The receptor target and the experimental setting both matter when interpreting a result.
Reading and sources
Cell Metabolism · LY3437943Put the profiles side by side
Compare research directions and labelled formats. Choose a related material to explore the difference.
Retatrutide
Three metabolic targets, one peptide: GLP-1, GIP and glucagon in weight-regulation research.
Tirzepatide
Appetite and glucose balance: a dual GLP-1/GIP peptide at the heart of metabolic research.
A closer look at the details
What is Retatrutide?
A synthetic investigational peptide that activates the GLP-1, GIP and glucagon receptors simultaneously. It was developed by Eli Lilly and remains in clinical trials, it is not an approved medicine. Listed here as a non-clinical research material only.
How is Retatrutide different from Tirzepatide?
Tirzepatide is a dual agonist: it targets GLP-1 and GIP. Retatrutide adds a third target, the glucagon receptor. That extra arm is the main reason the two are compared in metabolic research.
What does the amount on the label mean?
The label records the amount or volume in the vial. It identifies the format; it does not define a use regimen.
Research context, not a promise of clinical effects. Read each study in its original experimental setting.
Available options.
Retatrutide
What is Retatrutide?
A synthetic investigational peptide that activates the GLP-1, GIP and glucagon receptors simultaneously. It was developed by Eli Lilly and remains in clinical trials, it is not an approved medicine. Listed here as a non-clinical research material only.
How is Retatrutide different from Tirzepatide?
Tirzepatide is a dual agonist: it targets GLP-1 and GIP. Retatrutide adds a third target, the glucagon receptor. That extra arm is the main reason the two are compared in metabolic research.
How do I check Retatrutide availability?
Tap “Order” and choose WhatsApp or Telegram. Your chosen app opens a short message with Retatrutide 10 mg / 20 mg. Send it to check availability.
Can I pay directly on the website?
No. After confirmation, payment is accepted in VND or USD.



